Nov. 10 2022
Source Page: Cabozantinib for previously treated advanced hepatocellular carcinomaFound: death-1; PD-L1, program med cell death ligand 1.
Oct. 05 2022
Source Page: Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapyFound: emic myelosis or diguglielmo* or di guglielmo* ).tw,kf.13447 11 ((mast-cell* or mastcell*) adj2 leu
May. 31 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 13 December 2021Found: tendency to bruise20 Eosinophilic disorders Eosinophilia10 Haematological disorders Mast
May. 31 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 27 December 2021Found: Antiphospholipid syndrome10 Coagulopathy10 Haematological disorders Blood disorder10 Mast
May. 31 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 27 December 2021Found: cell activation syndrome100 Mastocytosis30 Methaemoglobinaemia10 Haemolyses NEC
May. 31 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 13 December 2021Found: Increased tendency to bruise10 Coagulopathies Coagulopathy10 Haematological disorders Mast
May. 31 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 27 December 2021Found: Antiphospholipid syndrome10 Coagulopathy10 Haematological disorders Blood disorder10 Mast
Oct. 24 2022
Source Page: Code of safe working practices for merchant seafarers (COSWP) amendment 7 2022Found: not possible for them to conduct a risk assessment for changing a navigation light bulb up the main mast
May. 26 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 8 November 2021Found: Eosinophilic disorders Eosinophilia10 Haematological disorders Blood disorder10 Mast
May. 26 2022
Source Page: Freedom of Information responses from the MHRA - week commencing 22 November 2021Found: Eosinophilic disorders Eosinophilia10 Haematological disorders Blood disorder10 Mast